Ding H, Nguyen H, Li W, Deshpande A, Zhang S, Jiang F
J Virol. 2024; 98(12):e0172024.
PMID: 39508605
PMC: 11650979.
DOI: 10.1128/jvi.01720-24.
Raines S, Falcinelli S, Peterson J, Van Gulck E, Allard B, Kirchherr J
Antimicrob Agents Chemother. 2024; 68(7):e0020124.
PMID: 38829049
PMC: 11232404.
DOI: 10.1128/aac.00201-24.
Patarca R, Haseltine W
Int J Mol Sci. 2024; 25(6).
PMID: 38542351
PMC: 10970485.
DOI: 10.3390/ijms25063378.
Wang Q, Zhang S, Nguyen H, Sodroski J
J Virol. 2024; 98(2):e0159423.
PMID: 38289101
PMC: 10878270.
DOI: 10.1128/jvi.01594-23.
Gotora P, van der Sluis R, Williams M
BMC Infect Dis. 2023; 23(1):164.
PMID: 36932337
PMC: 10020771.
DOI: 10.1186/s12879-023-08123-0.
Nonsuppressible viremia during HIV-1 therapy meets molecular virology.
Emery A, Joseph S, Swanstrom R
J Clin Invest. 2023; 133(6).
PMID: 36919694
PMC: 10014097.
DOI: 10.1172/JCI167925.
Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.
Matsuo M, Ueno T, Monde K, Sugata K, Tan B, Rahman A
Nat Commun. 2022; 13(1):2405.
PMID: 35504920
PMC: 9065021.
DOI: 10.1038/s41467-022-30029-9.
Block and Lock HIV Cure Strategies to Control the Latent Reservoir.
Ahlenstiel C, Symonds G, Kent S, Kelleher A
Front Cell Infect Microbiol. 2020; 10:424.
PMID: 32923412
PMC: 7457024.
DOI: 10.3389/fcimb.2020.00424.
Key Players in HIV-1 Transcriptional Regulation: Targets for a Functional Cure.
Mori L, Valente S
Viruses. 2020; 12(5).
PMID: 32403278
PMC: 7291152.
DOI: 10.3390/v12050529.
Bioisosteric Replacement as a Tool in Anti-HIV Drug Design.
Dick A, Cocklin S
Pharmaceuticals (Basel). 2020; 13(3).
PMID: 32121077
PMC: 7151723.
DOI: 10.3390/ph13030036.
Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A.
Rice A
mBio. 2019; 10(4).
PMID: 31289189
PMC: 6747727.
DOI: 10.1128/mBio.01547-19.
Role of the Ubiquitin Proteasome System (UPS) in the HIV-1 Life Cycle.
Rojas V, Park I
Int J Mol Sci. 2019; 20(12).
PMID: 31248071
PMC: 6628307.
DOI: 10.3390/ijms20122984.
40 years of the human T-cell leukemia virus: past, present, and future.
Tagaya Y, Matsuoka M, Gallo R
F1000Res. 2019; 8.
PMID: 30854194
PMC: 6396841.
DOI: 10.12688/f1000research.17479.1.
Absence of interaction between porcine endogenous retrovirus and porcine cytomegalovirus in pig-to-baboon renal xenotransplantation in vivo.
Fishman J, Sachs D, Yamada K, Wilkinson R
Xenotransplantation. 2018; 25(5):e12395.
PMID: 29624743
PMC: 6158079.
DOI: 10.1111/xen.12395.
In cell mutational interference mapping experiment (in cell MIME) identifies the 5' polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging.
Smyth R, Smith M, Jousset A, Despons L, Laumond G, Decoville T
Nucleic Acids Res. 2018; 46(9):e57.
PMID: 29514260
PMC: 5961354.
DOI: 10.1093/nar/gky152.
Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.
Fitting S, McLaurin K, Booze R, Mactutus C
Int J Dev Neurosci. 2017; 65:66-82.
PMID: 29111178
PMC: 5889695.
DOI: 10.1016/j.ijdevneu.2017.10.009.
The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
Rice A
Curr Pharm Des. 2017; 23(28):4098-4102.
PMID: 28677507
PMC: 5700838.
DOI: 10.2174/1381612823666170704130635.
HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.
Krogh K, Lyddon E, Thayer S
J Neurochem. 2014; 132(3):354-66.
PMID: 25156524
PMC: 4304915.
DOI: 10.1111/jnc.12936.
Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.
Fitting S, Ignatowska-Jankowska B, Bull C, Skoff R, Lichtman A, Wise L
Biol Psychiatry. 2012; 73(5):443-53.
PMID: 23218253
PMC: 3570635.
DOI: 10.1016/j.biopsych.2012.09.026.
HIV persistence: chemokines and their signalling pathways.
Evans V, Khoury G, Saleh S, Cameron P, Lewin S
Cytokine Growth Factor Rev. 2012; 23(4-5):151-7.
PMID: 22749173
PMC: 4062707.
DOI: 10.1016/j.cytogfr.2012.05.002.